Good Samaritan Oncology Services. Vincennes, Indiana

Transcription

1 Good Samaritan Oncology Services Vincennes, Indiana

2 } Classified as a Community Cancer Center by CoC >100 and < 500 newly diagnosed cases each year Provide a full range of diagnostic and treatment services. Some referral of services } 2 Navigators Both are RN, OCN 1 Specific to Breast Cancer } 2 Multi-Disciplinary Cancer Conferences 1 Specific to Breast Cancer } Survivor Support Group

3

4 } Identifying patients eligible for SCP Primary tool is tracking spreadsheet Step one check schedules daily for new patient consults Step two Determine if they will qualify for SCP, Stage I, II, or III who are treated with curative intent for initial cancer occurrence upon completion of treatment Review MD note Review Pathology Tumor Registry data is used retrospectively to verify none who qualify were missed

5 } Non-Breast Tracking Tool Oncology Navigator- Current Pa4ents Name MD Diagnosis Dx Date Stage Tx Goal Chemo Dates RadTx Dates Concur rent Tx Type Next MD appt Surgery Date Notes NSCLC 12/29/15 IIIB Cure 1/25/16-3/ 23/16 1/25/16-4/ 5/16 yes CR 5/24/16 Pa9ent passed 5/19/16 Glioblastoma 11/17/15 IV Cure 1/6/ /6/16-2/1 9/16 yes* CR 6/30/16 Nov *on oral Temodar Sq cell tongue 04/29/16 IVA Cure 5/24/ /24/ yes CR 6/7/16 port placed 5/19/16 Cervical Adeno 03/14/16 IIA2 Cure 4/25/ /25/ yes CR 6/6/16 Lung adeno ca 02/02/16 IIA Cure 2/19/16-4/ 22/16 NA no CS 6/1716 pending neoadjuvant; possible mets neck Sq cell cervix 07/28/15 ct1an0m 0 Cure 11/2/15-12 /16/15 11/2/15-12 /18/15 yes 5/26/16 Small cell lung 01/26/16 IB Cure 2/15/ /15/16-3/ 30/16 yes CR 6/20/16

6 } Breast Tracking Tool name phone number dx date ER/PR status HER2 Status Staging Surgery type surgery date chemotherapy radia4on Endocrine therapy needs interven4on SCP Surgeon Oncologist Rad Onc TC + Hercep9n comp comp 7/7/2015 ER+ PR+ Pos IIB T2N0M0 L mastectomy 2/15/2016 in 7/16 05/24/2016 Arimidex 5/27/2016 8/3/2015 ER+ PR + Neg II T1N1M0 L lumpectomy 9/9/2015 TC comp. 12/10/15 comp. 03/02/16 Arimidex 4/18/ /6/2015 ER+ PR + Pos IIIB T4N1M0 L mastectomy 3/28/2016 TCHP comp. 02/26/16 start 5/31/2016 Arimidex financial tricap, calendar 10/27/201 5 Er+ PR- Pos IIB T2N1M0 11/3/2015 ER+ PR+ Neg I T1N0M0 L Lumpectomy 3/30/2016 TCHP start R Lumpectomy 11/13/2015 TC comp. 03/09/16 start 4/26/ /5/2015 ER+ PR+ Neg III T2N1M0 L mastectomy 12/7/2015? At IU 11/17/201 5 ER+ PR+ Neg I T1N0M0 11/30/201 5 ER+ PR+ Neg I T1N0M0 R TC 2 cycles stopped Lumpectomy 1/6/ /07/16 start 04/28/2016 Tamoxifen L Lumpectomy 11/30/2015 no completed Arimidex 4/18/ /1/2016 ER+ PR+ I T1N0M0 R mastectomy 5/20/ /15/201 5 ER+ PR+ Neg II T2N1M0 R Lumpectomy 1/11/2016 TC comp. 04/25/2016 started 5/31/16 financial tricap, gas cards

7 Pa9ent Name: Pa9ent phone: Informa4on Primary Care Provider: Surgeon: Radia9on Oncologist: Medical Oncologist: Other Providers: Cancer Type/Loca9on/Histology Subtype: Stage: I II III Not applicable Pa9ent DOB: Health Care Providers (Including Names, Ins9tu9on) Treatment Summary Diagnosis Diagnosis Date (year): General Coordina9ng Provider Cancer surveillance or other recommended related tests What/When/How Ohen Please con9nue to see your primary care provider for all general health care recommended for a (man) (woman) your age, including cancer screening tests. Any symptoms should be brought to the aien9on of your provider: 1. Anything that represents a brand new symptom; 2. Anything that represents a persistent symptom; 3. Anything you are worried about that might be related to the cancer coming back. Surgery Yes No Treatment Surgery Date(s) (year): Possible late- and long- term effects that someone with this type of cancer and treatment may experience: Surgical procedure/loca9on/findings: Radia9on Yes No Body area treated: Systemic Therapy (chemotherapy, hormonal therapy, other) Yes No Names of Agents Used End Date (year): Persistent symptoms or side effects at comple9on of treatment: No Yes (enter type(s)) : End Dates (year) Cancer survivors may experience issues with the areas listed below. If you have any concerns in these or other areas, please speak with your doctors or nurses to find out how you can get help with them. Emo9onal and mental health Fa9gue Weight changes Stopping smoking Physical Func9oning Insurance School/Work Financial advice or assistance Memory or concentra9on loss Paren9ng Fer9lity Sexual func9oning Other Risk Assessment Gene9c/hereditary risk factor(s) or predisposing condi9ons: Gene9c counseling: Yes No Gene9c tes9ng results: Need for ongoing (adjuvant) treatment for cancer Yes No Addi9onal treatment name Follow- up Care Plan Plan ned dur a9o n Possible Side effects Familial Cancer A number of lifestyle/behaviors can affect your ongoing health, including the risk for the cancer coming back or developing another cancer. Discuss these recommenda9ons with your doctor or nurse: Tobacco use/cessa9on Diet Alcohol use Sun screen use Weight management (loss/gain) Physical ac9vity Resources you may be interested in: Other comments: Coordina9ng Provider Schedule of clinical visits When/How ohen Prepared by: Delivered on:

8 } Navigators are responsible for the SCP process } SCP is started as soon as patient is identified as eligible } Adjustments are made if/when a change in patient treatment goal or stage is identified

9 } Upon completion of treatment the Navigator provides the SCP to the appropriate oncology physicians for review and finalization } SCP is presented by Navigator to patient in 1:1 meeting } SCP is provided to the patient s Primary Care Provider by emr or mail

10 } CoC Documentation Requirements

11 } Changes in staff New Medical Director of Oncology 2015 One Navigator No Social Services support until May 2015 } No emr Challenges obtaining big picture due to multiple paper charts Challenges with data monitoring and collection } Failed electronic software } Physician support

12 } Capturing surgery only patients } Timing of SCP presentation meeting within CoC requirements } Potential duplication when patient receives part of treatment at other facility

13 } Achieved CoC requirement of 10% } Improved physician support } Increased staff Addition of Oncology Social Worker in May of Navigators beginning 2016 } In process of limited emr implementation

14 Year 2015 Number of eligible patients 204 Number of patients refused 0 Number of 'no shows' 0 Number of eligible patients who have received SCPs 20 Percentage 10% 20/204 = 10%